A Multicenter, Open-Label, Noncomparative Study for the International Maternal, Pediatric, Adolescent AIDS Clinical Trials Group to Evaluate the Safety, Pharmacokinetics, and Antiretroviral Activity of MK-0518 in HIV-1 Infected Children (Study)

Grant

Date/time Interval

  • December 1, 2010 - December 31, 2013
  • Total Award Amount

  • 481959.00
  • Direct Costs

  • 415235.00
  • Sponsor Award Id

  • CRB-IPHRM-S-10-00263
  • Contributor

  • Acosta Pharm.D., Edward   Principal Investigator